{"id":23546,"date":"2026-04-16T10:38:02","date_gmt":"2026-04-16T14:38:02","guid":{"rendered":"https:\/\/www.ices.on.ca\/?post_type=private_project&p=23546"},"modified":"2026-04-16T10:38:03","modified_gmt":"2026-04-16T14:38:03","slug":"linking-registry-and-administrative-data-in-ontario-to-study-characteristics-and-outcomes-of-patients-with-nmosd","status":"publish","type":"private_project","link":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/linking-registry-and-administrative-data-in-ontario-to-study-characteristics-and-outcomes-of-patients-with-nmosd\/","title":{"rendered":"Linking Registry and Administrative Data in Ontario to Study Characteristics and Outcomes of Patients with NMOSD"},"content":{"rendered":"

Client:<\/strong> IQVIA Solutions Canada Inc.<\/p>\n

Project ID:<\/strong> P2024-227\/ 2026 0980 013 000<\/p>\n

Research Question\/Objectives:<\/strong> Neuromyelitis Optica Spectrum Disorder (NMOSD), also known as Neuromyelitis Optica or Devic disease, is a rare autoimmune condition of the central nervous system characterized by inflammation, demyelination, and damage to the optic nerves, spinal cord, and brain. It is often misdiagnosed as multiple sclerosis (MS) but requires distinct treatment and management.<\/p>\n

Given the high prevalence of anti-aquaporin-4 (anti-AQP4) and myelin oligodendrocyte glycoprotein (MOG) antibodies in NMOSD patients, and the significant impact of relapses on patient health and healthcare costs, there is a critical need for real-world evidence on NMOSD in Ontario to inform better management and treatment strategies.<\/p>\n

Objectives:\u00a0<\/strong><\/p>\n

The primary objectives of the study are to:<\/p>\n

    \n
  1. Describe the demographic, socioeconomic, and clinical characteristics of NMOSD patients and matched controls in Ontario, Canada.<\/li>\n
  2. Describe all-cause healthcare resource utilization (HCRU) and direct costs of NMOSD patients and matched controls in Ontario, Canada.<\/li>\n
  3. Describe clinical outcomes of NMOSD patients in Ontario, Canada.<\/li>\n<\/ol>\n

    Additionally, the study will examine the following exploratory objective(s):<\/p>\n

      \n
    1. Explore variations in the primary objectives across course of disease and NMOSD sub-populations in Ontario, Canada.<\/li>\n
    2. Explore treatment patterns of NMOSD patients and NMOSD sub-populations in Ontario, Canada.<\/li>\n
    3. Describe the demographic, socioeconomic, and clinical characteristics of matched multiple sclerosis (MS) patients in Ontario, Canada.<\/li>\n
    4. Describe all-cause healthcare resource utilization (HCRU) and direct costs of matched MS patients in Ontario, Canada.<\/li>\n<\/ol>\n

      Status:<\/strong> In progress<\/p>\n","protected":false},"excerpt":{"rendered":"

      Client: IQVIA Solutions Canada Inc. Project ID: P2024-227\/ 2026 0980 013 000 Research Question\/Objectives: Neuromyelitis Optica Spectrum Disorder (NMOSD), also known as Neuromyelitis Optica or Devic disease, is a rare autoimmune condition of the central nervous system characterized by inflammation, demyelination, and damage to the optic nerves, spinal cord, and brain. It is often misdiagnosed […]<\/p>\n","protected":false},"template":"","organization_type":[],"project_status":[104],"response_type":[],"class_list":["post-23546","private_project","type-private_project","status-publish","hentry","project_status-in-progress"],"acf":{"project_id":"P2024-227\/ 2026 0980 013 000","project_id_year":2026,"project_id_index":76,"ices_scientist":"","principal_investigators":null,"knowledge_user":"","client":"","objectives":"","results":"","availability_of_results":"","pia_approved":null,"infographic":"","sitecore_item_id":"","sitecore_item_name":"","sitecore_field_values":""},"yoast_head":"\nLinking Registry and Administrative Data in Ontario to Study Characteristics and Outcomes of Patients with NMOSD | ICES<\/title>\n<meta name=\"description\" content=\"Client: IQVIA Solutions Canada Inc. Project ID: P2024-227\/ 2026 0980 013 000 Research Question\/Objectives: Neuromyelitis Optica Spectrum Disorder (NMOSD),\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/linking-registry-and-administrative-data-in-ontario-to-study-characteristics-and-outcomes-of-patients-with-nmosd\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Linking Registry and Administrative Data in Ontario to Study Characteristics and Outcomes of Patients with NMOSD | ICES\" \/>\n<meta property=\"og:description\" content=\"Client: IQVIA Solutions Canada Inc. Project ID: P2024-227\/ 2026 0980 013 000 Research Question\/Objectives: Neuromyelitis Optica Spectrum Disorder (NMOSD),\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/linking-registry-and-administrative-data-in-ontario-to-study-characteristics-and-outcomes-of-patients-with-nmosd\/\" \/>\n<meta property=\"og:site_name\" content=\"ICES\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ICESOntario\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-16T14:38:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/linking-registry-and-administrative-data-in-ontario-to-study-characteristics-and-outcomes-of-patients-with-nmosd\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/linking-registry-and-administrative-data-in-ontario-to-study-characteristics-and-outcomes-of-patients-with-nmosd\\\/\",\"name\":\"Linking Registry and Administrative Data in Ontario to Study Characteristics and Outcomes of Patients with NMOSD | ICES\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\"},\"datePublished\":\"2026-04-16T14:38:02+00:00\",\"dateModified\":\"2026-04-16T14:38:03+00:00\",\"description\":\"Client: IQVIA Solutions Canada Inc. Project ID: P2024-227\\\/ 2026 0980 013 000 Research Question\\\/Objectives: Neuromyelitis Optica Spectrum Disorder (NMOSD),\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/linking-registry-and-administrative-data-in-ontario-to-study-characteristics-and-outcomes-of-patients-with-nmosd\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/linking-registry-and-administrative-data-in-ontario-to-study-characteristics-and-outcomes-of-patients-with-nmosd\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/linking-registry-and-administrative-data-in-ontario-to-study-characteristics-and-outcomes-of-patients-with-nmosd\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Private Sector Projects\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Linking Registry and Administrative Data in Ontario to Study Characteristics and Outcomes of Patients with NMOSD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"name\":\"ICES\",\"description\":\"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\"},\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\",\"name\":\"ICES\",\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"width\":\"676\",\"height\":\"618\",\"caption\":\"ICES\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ICESOntario\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ices-research-institute\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Linking Registry and Administrative Data in Ontario to Study Characteristics and Outcomes of Patients with NMOSD | ICES","description":"Client: IQVIA Solutions Canada Inc. Project ID: P2024-227\/ 2026 0980 013 000 Research Question\/Objectives: Neuromyelitis Optica Spectrum Disorder (NMOSD),","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/linking-registry-and-administrative-data-in-ontario-to-study-characteristics-and-outcomes-of-patients-with-nmosd\/","og_locale":"fr_FR","og_type":"article","og_title":"Linking Registry and Administrative Data in Ontario to Study Characteristics and Outcomes of Patients with NMOSD | ICES","og_description":"Client: IQVIA Solutions Canada Inc. Project ID: P2024-227\/ 2026 0980 013 000 Research Question\/Objectives: Neuromyelitis Optica Spectrum Disorder (NMOSD),","og_url":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/linking-registry-and-administrative-data-in-ontario-to-study-characteristics-and-outcomes-of-patients-with-nmosd\/","og_site_name":"ICES","article_publisher":"https:\/\/www.facebook.com\/ICESOntario\/","article_modified_time":"2026-04-16T14:38:03+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/linking-registry-and-administrative-data-in-ontario-to-study-characteristics-and-outcomes-of-patients-with-nmosd\/","url":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/linking-registry-and-administrative-data-in-ontario-to-study-characteristics-and-outcomes-of-patients-with-nmosd\/","name":"Linking Registry and Administrative Data in Ontario to Study Characteristics and Outcomes of Patients with NMOSD | ICES","isPartOf":{"@id":"https:\/\/www.ices.on.ca\/fr\/#website"},"datePublished":"2026-04-16T14:38:02+00:00","dateModified":"2026-04-16T14:38:03+00:00","description":"Client: IQVIA Solutions Canada Inc. Project ID: P2024-227\/ 2026 0980 013 000 Research Question\/Objectives: Neuromyelitis Optica Spectrum Disorder (NMOSD),","breadcrumb":{"@id":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/linking-registry-and-administrative-data-in-ontario-to-study-characteristics-and-outcomes-of-patients-with-nmosd\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/linking-registry-and-administrative-data-in-ontario-to-study-characteristics-and-outcomes-of-patients-with-nmosd\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/linking-registry-and-administrative-data-in-ontario-to-study-characteristics-and-outcomes-of-patients-with-nmosd\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ices.on.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Private Sector Projects","item":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/"},{"@type":"ListItem","position":3,"name":"Linking Registry and Administrative Data in Ontario to Study Characteristics and Outcomes of Patients with NMOSD"}]},{"@type":"WebSite","@id":"https:\/\/www.ices.on.ca\/fr\/#website","url":"https:\/\/www.ices.on.ca\/fr\/","name":"ICES","description":"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE","publisher":{"@id":"https:\/\/www.ices.on.ca\/fr\/#organization"},"alternateName":"Institute for Clinical Evaluative Sciences","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ices.on.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ices.on.ca\/fr\/#organization","name":"ICES","alternateName":"Institute for Clinical Evaluative Sciences","url":"https:\/\/www.ices.on.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","contentUrl":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","width":"676","height":"618","caption":"ICES"},"image":{"@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ICESOntario\/","https:\/\/www.linkedin.com\/company\/ices-research-institute\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/private_project\/23546","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/private_project"}],"about":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/types\/private_project"}],"wp:attachment":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/media?parent=23546"}],"wp:term":[{"taxonomy":"organization_type","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/organization_type?post=23546"},{"taxonomy":"project_status","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/project_status?post=23546"},{"taxonomy":"response_type","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/response_type?post=23546"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}